au.\*:("the Japanese Solifenacin Study Group")
Results 1 to 1 of 1
Selection :
Randomized, double-blind, placebo-and propiverine-controlled trial of the once-daily antimuscarinic agent solifenacin in Japanese patients with overactive bladderYAMAGUCHI, Osamu; MARUI, Eiji; SEKI, Narihito et al.BJU international (Papier). 2007, Vol 100, Num 3, pp 579-587, issn 1464-4096, 9 p.Article
